AlphaGrep UK Ltd’s Eastman Chemical EMN Stock Holding History

AlphaGrep UK Ltd’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,149	Closed	-$201K	–	831
2025 Q4	$201K	Buy	+3,149	New	+$194K	0.07%	627

Other funds holding EMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

AlphaGrep UK Ltd's EMN Position: Q1 2026 in Review

AlphaGrep UK Ltd sold out of Eastman Chemical (EMN) in Q1 2026, closing a stake of 3,149 shares — an estimated $201K sold.

AlphaGrep UK Ltd first reported a position in EMN in Q4 2025 and held it in 1 quarter. The position peaked at $201K in Q4 2025. 637 funds tracked by Wall St. Rank hold EMN as of Q1 2026.

AlphaGrep UK Ltd reported no remaining Eastman Chemical position as of Q1 2026 after selling out during the quarter.
AlphaGrep UK Ltd sold 3,149 Eastman Chemical shares in Q1 2026, an estimated $201K.
AlphaGrep UK Ltd first reported a position in Eastman Chemical in Q4 2025 and held it in 1 quarter.
AlphaGrep UK Ltd's Eastman Chemical position peaked at $201K in Q4 2025.
637 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.